{"transactions":[{"id":4633126,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":29902,"kind":"person","name":"Strahley John","position":1,"cik":"0001875425","reported_name":"Strahley John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-10-03T01:00:35.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":97417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"48,708 shares vested on September 15, 2026. 24,354 shares vested on September 30, 2026. 24,355 shares will vest on October 15, 2026."}],"balance_after":97417,"derivative":{"exercise_price":0.3,"expiration_date":"2036-09-08","underlying":"Common Stock","underlying_shares":97417},"source":{"system":"sec-edgar","filing":"0001493152-26-045579","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226045579/ownership.xml","form_type":"4"}},{"id":707414,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":29902,"kind":"person","name":"Strahley John","position":1,"cik":"0001875425","reported_name":"Strahley John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-17T22:33:23.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This form is being filed to correct the number of options awarded."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"17,500 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months."}],"balance_after":70000,"derivative":{"exercise_price":0.5,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-26-033814","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226033814/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-15"}},{"id":709291,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":29902,"kind":"person","name":"Strahley John","position":1,"cik":"0001875425","reported_name":"Strahley John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-15T20:51:08.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"18,750 shares will vest on July 26, 2026. The remaining shares will vest in equal monthly installments over the next 9 months."}],"balance_after":75000,"derivative":{"exercise_price":0.5,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-26-033384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226033384/ownership.xml","form_type":"4"}},{"id":745326,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2026-06-09T20:53:09.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the \"Living Trust\") and in such capacity may be deemed to beneficially own the securities held by the Living Trust."}],"balance_after":300000,"derivative":{"exercise_price":0.75,"exercise_date":"2026-06-05","expiration_date":"2029-06-05","underlying":"Common Stock, par value $0.001","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-26-027952","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226027952/ownership.xml","form_type":"4"}},{"id":745325,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T20:53:09.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":222222,"price":0.45,"value":99999.9,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the \"Living Trust\") and in such capacity may be deemed to beneficially own the securities held by the Living Trust."}],"balance_after":4046051,"source":{"system":"sec-edgar","filing":"0001493152-26-027952","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226027952/ownership.xml","form_type":"4"}},{"id":759270,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T20:07:21.000Z","date":"2025-09-17","kind":"other","planned":false,"acquired":true,"shares":11112,"price":0.45,"value":5000.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired as payment to Dr. Cohen from another party in settlement of another property."}],"balance_after":386018,"source":{"system":"sec-edgar","filing":"0001493152-26-026359","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226026359/ownership.xml","form_type":"4"}},{"id":759269,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43282,"kind":"person","name":"Fraser John D","position":1,"cik":"0001769195","reported_name":"Fraser John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2026-05-29T20:05:09.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":12292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This report is being filed to correct the number of shares indirectly held by Mr. Fraser on September 17, 2025 and the presentation of the warrants held on September 17, 2025."}],"balance_after":12292,"derivative":{"exercise_price":0.75,"exercise_date":"2025-09-17","expiration_date":"2030-09-17","underlying":"Common Stock, par value $0.001","underlying_shares":12292},"source":{"system":"sec-edgar","filing":"0001493152-26-026346","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226026346/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-19"}},{"id":759268,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43282,"kind":"person","name":"Fraser John D","position":1,"cik":"0001769195","reported_name":"Fraser John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T20:05:09.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":16389,"price":0.45,"value":7375.05,"ownership":{"direct":true},"balance_after":566393,"source":{"system":"sec-edgar","filing":"0001493152-26-026346","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226026346/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-19"}},{"id":759267,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2026-05-29T20:05:07.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025."}],"balance_after":41667,"derivative":{"exercise_price":0.75,"exercise_date":"2025-09-17","expiration_date":"2030-09-17","underlying":"Common Stock, par value $0.001","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001493152-26-026345","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226026345/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-19"}},{"id":759266,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T20:05:07.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":55556,"price":0.45,"value":25000.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025."}],"balance_after":374906,"source":{"system":"sec-edgar","filing":"0001493152-26-026345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315226026345/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-19"}},{"id":980670,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72223,"kind":"person","name":"Hundorfean Cynthia D","position":1,"cik":"0002065631","reported_name":"Hundorfean Cynthia D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-04T14:05:08.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":238085,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":238085,"derivative":{"exercise_price":0.35,"exercise_date":"2025-12-02","expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":238085},"source":{"system":"sec-edgar","filing":"0001493152-25-026119","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225026119/ownership.xml","form_type":"4"}},{"id":980671,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43282,"kind":"person","name":"Fraser John D","position":1,"cik":"0001769195","reported_name":"Fraser John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-04T13:33:03.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":314811,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":314811,"derivative":{"exercise_price":0.35,"exercise_date":"2025-12-02","expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":314811},"source":{"system":"sec-edgar","filing":"0001493152-25-026110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225026110/ownership.xml","form_type":"4"}},{"id":982521,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72321,"kind":"person","name":"Wood Jane Pine","position":1,"cik":"0001810531","reported_name":"Wood Jane Pine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-04T02:33:44.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":135592,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":135592,"derivative":{"exercise_price":0.35,"exercise_date":"2025-12-02","expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":135592},"source":{"system":"sec-edgar","filing":"0001493152-25-026078","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225026078/ownership.xml","form_type":"4"}},{"id":982520,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-04T02:32:26.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":185178,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":185178,"derivative":{"exercise_price":0.35,"exercise_date":"2025-12-02","expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":185178},"source":{"system":"sec-edgar","filing":"0001493152-25-026076","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225026076/ownership.xml","form_type":"4"}},{"id":982519,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-04T02:30:55.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":213518,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":213518,"derivative":{"exercise_price":0.35,"exercise_date":"2025-12-02","expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":213518},"source":{"system":"sec-edgar","filing":"0001493152-25-026074","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225026074/ownership.xml","form_type":"4"}},{"id":982518,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72319,"kind":"person","name":"Beausang Ellen","position":1,"cik":"0002061533","reported_name":"Beausang Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-04T02:29:01.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":198097,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":198097,"derivative":{"exercise_price":0.35,"exercise_date":"2025-12-02","expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":198097},"source":{"system":"sec-edgar","filing":"0001493152-25-026071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225026071/ownership.xml","form_type":"4"}},{"id":1035831,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2025-09-19T21:26:10.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":833333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the \"Living Trust\") and in such capacity may be deemed to beneficially own the securities held by the Living Trust."}],"balance_after":833333,"derivative":{"exercise_price":0.75,"exercise_date":"2025-09-17","expiration_date":"2030-09-17","underlying":"Common Stock, par value $0.001","underlying_shares":833333},"source":{"system":"sec-edgar","filing":"0001493152-25-014334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225014334/ownership.xml","form_type":"4"}},{"id":1035830,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T21:26:10.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":1111111,"price":0.45,"value":499999.95,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the \"Living Trust\") and in such capacity may be deemed to beneficially own the securities held by the Living Trust."}],"balance_after":3823829,"source":{"system":"sec-edgar","filing":"0001493152-25-014334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225014334/ownership.xml","form_type":"4"}},{"id":1035829,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2025-09-19T21:26:04.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":491985,"derivative":{"exercise_price":0.75,"exercise_date":"2025-09-17","expiration_date":"2030-09-17","underlying":"Common Stock, par value $0.001","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001493152-25-014333","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225014333/ownership.xml","form_type":"4"}},{"id":1035828,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T21:26:04.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":55556,"price":0.45,"value":25000.2,"ownership":{"direct":false,"nature":"By HealthView Asset Management"},"balance_after":375697,"source":{"system":"sec-edgar","filing":"0001493152-25-014333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225014333/ownership.xml","form_type":"4"}},{"id":1035827,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43282,"kind":"person","name":"Fraser John D","position":1,"cik":"0001769195","reported_name":"Fraser John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2025-09-19T20:05:24.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":12292,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":981549,"derivative":{"exercise_price":0.75,"exercise_date":"2025-09-17","expiration_date":"2030-09-17","underlying":"Common Stock, par value $0.001","underlying_shares":12292},"source":{"system":"sec-edgar","filing":"0001493152-25-014233","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225014233/ownership.xml","form_type":"4"}},{"id":1035826,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43282,"kind":"person","name":"Fraser John D","position":1,"cik":"0001769195","reported_name":"Fraser John D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-19T20:05:24.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":16389,"price":0.45,"value":7375.05,"ownership":{"direct":true},"balance_after":566393,"source":{"system":"sec-edgar","filing":"0001493152-25-014233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225014233/ownership.xml","form_type":"4"}},{"id":1048646,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":75810,"kind":"person","name":"Hungerford Brian","position":1,"cik":"0001981345","reported_name":"Hungerford Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-04T20:05:28.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25,000 shares will vest on September 2, 2026. The remaining shares will vest in equal monthly installments over the next 36 months."}],"balance_after":100000,"derivative":{"exercise_price":0.41,"expiration_date":"2035-09-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001641172-25-026580","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225026580/ownership.xml","form_type":"4"}},{"id":1120330,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-06T20:05:21.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5312},"source":{"system":"sec-edgar","filing":"0001641172-25-014017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225014017/ownership.xml","form_type":"4"}},{"id":1120329,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:05:21.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":73989,"source":{"system":"sec-edgar","filing":"0001641172-25-014017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225014017/ownership.xml","form_type":"4"}},{"id":1120328,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-06T11:53:02.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4844},"source":{"system":"sec-edgar","filing":"0001641172-25-013935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013935/ownership.xml","form_type":"4"}},{"id":1120327,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T11:53:02.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":134734,"source":{"system":"sec-edgar","filing":"0001641172-25-013935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013935/ownership.xml","form_type":"4"}},{"id":1121978,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T20:15:43.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":5937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5937},"source":{"system":"sec-edgar","filing":"0001641172-25-013811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013811/ownership.xml","form_type":"4"}},{"id":1121977,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:15:43.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":5937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":78726,"source":{"system":"sec-edgar","filing":"0001641172-25-013811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013811/ownership.xml","form_type":"4"}},{"id":1121976,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T20:06:24.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8437},"source":{"system":"sec-edgar","filing":"0001641172-25-013806","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013806/ownership.xml","form_type":"4"}},{"id":1121975,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:06:24.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":82502,"source":{"system":"sec-edgar","filing":"0001641172-25-013806","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013806/ownership.xml","form_type":"4"}},{"id":1121974,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T20:06:05.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":5156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5156},"source":{"system":"sec-edgar","filing":"0001641172-25-013804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013804/ownership.xml","form_type":"4"}},{"id":1121973,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:06:05.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":5156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":71209,"source":{"system":"sec-edgar","filing":"0001641172-25-013804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013804/ownership.xml","form_type":"4"}},{"id":1121972,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72319,"kind":"person","name":"Beausang Ellen","position":1,"cik":"0002061533","reported_name":"Beausang Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-05T20:05:56.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":4843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4843},"source":{"system":"sec-edgar","filing":"0001641172-25-013801","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013801/ownership.xml","form_type":"4"}},{"id":1121971,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72319,"kind":"person","name":"Beausang Ellen","position":1,"cik":"0002061533","reported_name":"Beausang Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T20:05:56.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":4843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025."}],"balance_after":6458,"source":{"system":"sec-edgar","filing":"0001641172-25-013801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013801/ownership.xml","form_type":"4"}},{"id":1123646,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T23:21:21.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":11653,"price":0.07,"value":815.71,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":60913,"source":{"system":"sec-edgar","filing":"0001641172-25-013689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013689/ownership.xml","form_type":"4"}},{"id":1123645,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":43281,"kind":"person","name":"cohen Jeffrey k","position":1,"cik":"0002071174","reported_name":"cohen Jeffrey k","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T23:21:21.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":44260,"price":0.07,"value":3098.2,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":49260,"source":{"system":"sec-edgar","filing":"0001641172-25-013689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225013689/ownership.xml","form_type":"4"}},{"id":1134106,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":79279,"kind":"person","name":"Buhle Michael William","position":1,"cik":"0002061539","reported_name":"Buhle Michael William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-27T10:37:52.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The employee stock option will vest in forty-eight equal monthly amounts beginning January 30, 2025."}],"balance_after":100000,"derivative":{"exercise_price":0.07,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001641172-25-012386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225012386/ownership.xml","form_type":"4"}},{"id":1184793,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-02T12:23:47.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":5312,"derivative":{"underlying":"Common Stock","underlying_shares":5313},"source":{"system":"sec-edgar","filing":"0001641172-25-002278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002278/ownership.xml","form_type":"4"}},{"id":1184792,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T12:23:47.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":68677,"source":{"system":"sec-edgar","filing":"0001641172-25-002278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002278/ownership.xml","form_type":"4"}},{"id":1187073,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-02T01:01:39.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":5156,"derivative":{"underlying":"Common Stock","underlying_shares":5156},"source":{"system":"sec-edgar","filing":"0001641172-25-002231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002231/ownership.xml","form_type":"4"}},{"id":1187072,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T01:01:39.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":66053,"source":{"system":"sec-edgar","filing":"0001641172-25-002231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002231/ownership.xml","form_type":"4"}},{"id":1187070,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72319,"kind":"person","name":"Beausang Ellen","position":1,"cik":"0002061533","reported_name":"Beausang Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-02T00:59:28.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":1615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":4843,"derivative":{"underlying":"Common Stock","underlying_shares":1615},"source":{"system":"sec-edgar","filing":"0001641172-25-002229","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002229/ownership.xml","form_type":"4"}},{"id":1187069,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72319,"kind":"person","name":"Beausang Ellen","position":1,"cik":"0002061533","reported_name":"Beausang Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T00:59:28.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":1615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025."}],"balance_after":1615,"source":{"system":"sec-edgar","filing":"0001641172-25-002229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002229/ownership.xml","form_type":"4"}},{"id":1187068,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72319,"kind":"person","name":"Beausang Ellen","position":1,"cik":"0002061533","reported_name":"Beausang Ellen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-02T00:57:34.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":false,"shares":6458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,615 RSUs will vest on March 31, 2025 and 4,843 RSUs will vest on date of the annual shareholders' meeting, subject to the Reporting Person's continued service to Aspira Women's Health Inc. through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1,615 RSUs will vest on March 31, 2025 and 4,843 RSUs will vest on date of the annual shareholders' meeting, subject to the Reporting Person's continued service to Aspira Women's Health Inc. through the applicable vesting dates."}],"balance_after":6458,"derivative":{"underlying":"Common Stock","underlying_shares":6458},"source":{"system":"sec-edgar","filing":"0001641172-25-002227","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002227/ownership.xml","form_type":"4"}},{"id":1187067,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-01T22:42:35.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":5937,"derivative":{"underlying":"Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0001641172-25-002184","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002184/ownership.xml","form_type":"4"}},{"id":1187066,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T22:42:35.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":72789,"source":{"system":"sec-edgar","filing":"0001641172-25-002184","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002184/ownership.xml","form_type":"4"}},{"id":1187065,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-01T22:42:33.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":4843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":4844,"derivative":{"underlying":"Common Stock","underlying_shares":4843},"source":{"system":"sec-edgar","filing":"0001641172-25-002183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002183/ownership.xml","form_type":"4"}},{"id":1187064,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T22:42:33.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":4843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":129890,"source":{"system":"sec-edgar","filing":"0001641172-25-002183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002183/ownership.xml","form_type":"4"}},{"id":1187063,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-01T22:42:32.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":8438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":8437,"derivative":{"underlying":"Common Stock","underlying_shares":8438},"source":{"system":"sec-edgar","filing":"0001641172-25-002186","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002186/ownership.xml","form_type":"4"}},{"id":1187062,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T22:42:32.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":8438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":74065,"source":{"system":"sec-edgar","filing":"0001641172-25-002186","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002186/ownership.xml","form_type":"4"}},{"id":1187061,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-01T22:42:31.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001641172-25-002185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002185/ownership.xml","form_type":"4"}},{"id":1187060,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T22:42:31.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":55665,"source":{"system":"sec-edgar","filing":"0001641172-25-002185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002185/ownership.xml","form_type":"4"}},{"id":1215903,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":23810,"kind":"person","name":"SCHULER JACK W","position":1,"cik":"0001021412","reported_name":"SCHULER JACK W","relationship":{"ten_percent_owner":true}}],"security":"Senior Secured Convertible Note due 2030","published_at":"2025-03-10T21:05:42.000Z","date":"2025-03-06","kind":"purchase","planned":false,"acquired":true,"price":200000,"reported_value":200000,"ownership":{"direct":false,"nature":"By Jack W. Schuler Living Trust"},"footnotes":[{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"On March 6, 2025, the Issuer issued to the Living Trust in a private transaction a Senior Secured Convertible Note due 2030 in the principal amount of $200,000 (the \"Convertible Note\"). Each $0.25 principal amount of the Convertible Note is convertible by its holder at any time prior to maturity into one \"Phase 1 Unit,\" consisting of (i) one share of Common Stock and (ii) a warrant to purchase, on the terms set forth therein, 2.25 shares of Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On March 6, 2025, the Issuer issued to the Living Trust in a private transaction a Senior Secured Convertible Note due 2030 in the principal amount of $200,000 (the \"Convertible Note\"). Each $0.25 principal amount of the Convertible Note is convertible by its holder at any time prior to maturity into one \"Phase 1 Unit,\" consisting of (i) one share of Common Stock and (ii) a warrant to purchase, on the terms set forth therein, 2.25 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the \"Living Trust\") and in such capacity may be deemed to beneficially own the securities held by the Living Trust."}],"derivative":{"exercise_price":0.25,"exercise_date":"2025-03-06","expiration_date":"2030-03-06","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0000908834-25-000098","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000090883425000098/form4.xml","form_type":"4"}},{"id":1292157,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-29T22:20:58.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001859810-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-01-08"}},{"id":1292156,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-01-29T22:20:58.000Z","date":"2025-01-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":6356,"price":0.7,"value":4449.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on December 31, 2024."},{"field":"kind","element":"transactionCoding","label":"F5","text":"This report is being filed to correct the number of shares held after tax withholding on the vesting of RSUs that vested on December 31, 2024."}],"balance_after":13644,"source":{"system":"sec-edgar","filing":"0001859810-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-01-08"}},{"id":1292155,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-01-29T22:20:58.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001859810-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-01-08"}},{"id":1307147,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-09T00:20:14.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":16875,"derivative":{"underlying":"Common Stock","underlying_shares":8437},"source":{"system":"sec-edgar","filing":"0001973204-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197320425000001/primary_doc.xml","form_type":"4"}},{"id":1307146,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-09T00:20:14.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":65627,"source":{"system":"sec-edgar","filing":"0001973204-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197320425000001/primary_doc.xml","form_type":"4"}},{"id":1307145,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-09T00:12:29.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001911051-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105125000001/primary_doc.xml","form_type":"4"}},{"id":1307144,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-09T00:12:29.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":50665,"source":{"system":"sec-edgar","filing":"0001911051-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105125000001/primary_doc.xml","form_type":"4"}},{"id":1307143,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-09T00:05:06.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":5157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,157 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,157 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":10312,"derivative":{"underlying":"Common Stock","underlying_shares":5157},"source":{"system":"sec-edgar","filing":"0001979704-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197970425000001/primary_doc.xml","form_type":"4"}},{"id":1307142,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-09T00:05:06.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":5157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,157 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":60897,"source":{"system":"sec-edgar","filing":"0001979704-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197970425000001/primary_doc.xml","form_type":"4"}},{"id":1307141,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-08T23:58:14.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":5937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":11875,"derivative":{"underlying":"Common Stock","underlying_shares":5937},"source":{"system":"sec-edgar","filing":"0001688530-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000168853025000001/primary_doc.xml","form_type":"4"}},{"id":1307140,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:58:14.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":5937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,937 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":66851,"source":{"system":"sec-edgar","filing":"0001688530-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000168853025000001/primary_doc.xml","form_type":"4"}},{"id":1307139,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-08T23:47:35.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":9687,"derivative":{"underlying":"Common Stock","underlying_shares":4844},"source":{"system":"sec-edgar","filing":"0002031593-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000203159325000001/primary_doc.xml","form_type":"4"}},{"id":1307138,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:47:35.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":125047,"source":{"system":"sec-edgar","filing":"0002031593-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000203159325000001/primary_doc.xml","form_type":"4"}},{"id":1307137,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & President"}}],"security":"Restricted Stock Units","published_at":"2025-01-08T23:35:40.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001859810-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000001/primary_doc.xml","form_type":"4"}},{"id":1307136,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & President"}}],"security":"Common Stock","published_at":"2025-01-08T23:35:40.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001859810-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000001/primary_doc.xml","form_type":"4"}},{"id":1307135,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-08T23:17:17.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":5312},"source":{"system":"sec-edgar","filing":"0001562180-25-000277","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218025000277/primarydocument.xml","form_type":"4"}},{"id":1307134,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:17:17.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":63364,"source":{"system":"sec-edgar","filing":"0001562180-25-000277","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218025000277/primarydocument.xml","form_type":"4"}},{"id":1355004,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-11-22T23:16:16.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"This report is being filed to correct the derivative securities from acquired to disposed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":14531,"derivative":{"underlying":"Common stock","underlying_shares":4844},"source":{"system":"sec-edgar","filing":"0002031593-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000203159324000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-10-02"}},{"id":1355003,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-22T23:16:16.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":120203,"source":{"system":"sec-edgar","filing":"0002031593-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000203159324000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2024-10-02"}},{"id":1365652,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":86113,"kind":"person","name":"Kallassy John A","position":1,"cik":"0001379818","reported_name":"Kallassy John A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-14T21:54:02.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.84,"exercise_date":"2024-11-12","expiration_date":"2027-11-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-24-007697","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218024007697/primarydocument.xml","form_type":"4"}},{"id":1367288,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock option (right to buy)","published_at":"2024-11-14T01:54:27.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.84,"exercise_date":"2024-11-12","expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001859810-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981024000005/primary_doc.xml","form_type":"4"}},{"id":1380821,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2024-10-28T22:54:49.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001859810-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981024000004/primary_doc.xml","form_type":"4"}},{"id":1380820,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":86533,"kind":"person","name":"Sandford Nicole","position":1,"cik":"0001849521","reported_name":"Sandford Nicole","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-28T22:47:01.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting\nPerson's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting\nPerson's continued service to the Issuer through the applicable vesting date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001849521-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000184952124000006/primary_doc.xml","form_type":"4"}},{"id":1392707,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-03T20:44:55.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":15937,"derivative":{"underlying":"Common Stock","underlying_shares":5313},"source":{"system":"sec-edgar","filing":"0001562180-24-007233","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218024007233/primarydocument.xml","form_type":"4"}},{"id":1392706,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-03T20:44:55.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":58052,"source":{"system":"sec-edgar","filing":"0001562180-24-007233","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218024007233/primarydocument.xml","form_type":"4"}},{"id":1395405,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-02T22:05:38.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":17812,"derivative":{"underlying":"Common Stock","underlying_shares":5938},"source":{"system":"sec-edgar","filing":"0001688530-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000168853024000002/primary_doc.xml","form_type":"4"}},{"id":1395404,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T22:05:38.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":5938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 23,750 RSUs, 5,938 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":60914,"source":{"system":"sec-edgar","filing":"0001688530-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000168853024000002/primary_doc.xml","form_type":"4"}},{"id":1395401,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-02T21:55:34.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":5156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":15469,"derivative":{"underlying":"Common Stock","underlying_shares":5156},"source":{"system":"sec-edgar","filing":"0001979704-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197970424000001/primary_doc.xml","form_type":"4"}},{"id":1395400,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:55:34.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":5156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,625 RSUs, 5,156 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":55740,"source":{"system":"sec-edgar","filing":"0001979704-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197970424000001/primary_doc.xml","form_type":"4"}},{"id":1395403,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-02T21:39:32.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":8438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":25312,"derivative":{"underlying":"Common Stock","underlying_shares":8438},"source":{"system":"sec-edgar","filing":"0001973204-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197320424000001/primary_doc.xml","form_type":"4"}},{"id":1395402,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:39:32.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":8438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,438 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":57190,"source":{"system":"sec-edgar","filing":"0001973204-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000197320424000001/primary_doc.xml","form_type":"4"}},{"id":1395399,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-02T21:31:07.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":14531,"derivative":{"underlying":"Common Stock","underlying_shares":4844},"source":{"system":"sec-edgar","filing":"0002031593-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000203159324000001/primary_doc.xml","form_type":"4"}},{"id":1395398,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:31:07.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":4844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":120203,"source":{"system":"sec-edgar","filing":"0002031593-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000203159324000001/primary_doc.xml","form_type":"4"}},{"id":1395397,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-02T21:19:48.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001911051-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105124000001/primary_doc.xml","form_type":"4"}},{"id":1395396,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:19:48.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":45665,"source":{"system":"sec-edgar","filing":"0001911051-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000191105124000001/primary_doc.xml","form_type":"4"}},{"id":1423602,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T20:42:10.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":21250,"derivative":{"underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0000950170-24-100573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100573/ownership.xml","form_type":"4"}},{"id":1423601,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T11:28:03.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":20625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":20625,"derivative":{"underlying":"Common Stock","underlying_shares":20625},"source":{"system":"sec-edgar","filing":"0000950170-24-100348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100348/ownership.xml","form_type":"4"}},{"id":1423600,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78811,"kind":"person","name":"Ragard John Phillip","position":1,"cik":"0002031593","reported_name":"Ragard John Phillip","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T11:25:32.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":19375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":19375,"derivative":{"underlying":"Common Stock","underlying_shares":19375},"source":{"system":"sec-edgar","filing":"0000950170-24-100346","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100346/ownership.xml","form_type":"4"}},{"id":1423599,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":86113,"kind":"person","name":"Kallassy John A","position":1,"cik":"0001379818","reported_name":"Kallassy John A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock option (right to buy)","published_at":"2024-08-26T11:21:38.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in six equal amounts, with 1/6 of the grant vesting upon the grant date and an additional 1/6 vesting each month thereafter."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2034-08-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-100343","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100343/ownership.xml","form_type":"4"}},{"id":1423598,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T11:18:32.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":33750,"derivative":{"underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0000950170-24-100341","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100341/ownership.xml","form_type":"4"}},{"id":1423597,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T11:16:12.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-100339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100339/ownership.xml","form_type":"4"}},{"id":1423596,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T11:14:53.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":23750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":23750,"derivative":{"underlying":"Common Stock","underlying_shares":23750},"source":{"system":"sec-edgar","filing":"0000950170-24-100336","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100336/ownership.xml","form_type":"4"}},{"id":1435257,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":81395,"kind":"person","name":"Fralick Celeste Rachelle","position":1,"cik":"0001911051","reported_name":"Fralick Celeste Rachelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:23:41.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":15381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024."}],"balance_after":40665,"source":{"system":"sec-edgar","filing":"0000950170-24-096277","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024096277/ownership.xml","form_type":"4"}},{"id":1435256,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":72320,"kind":"person","name":"Parnell Winfred","position":1,"cik":"0001979704","reported_name":"Parnell Winfred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:21:44.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":15803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024."}],"balance_after":50584,"source":{"system":"sec-edgar","filing":"0000950170-24-096268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024096268/ownership.xml","form_type":"4"}},{"id":1435255,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78854,"kind":"person","name":"Herchuk Jannie Prestridge","position":1,"cik":"0001973204","reported_name":"Herchuk Jannie Prestridge","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:20:00.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":20017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024."}],"balance_after":48752,"source":{"system":"sec-edgar","filing":"0000950170-24-096259","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024096259/ownership.xml","form_type":"4"}},{"id":1435254,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":78855,"kind":"person","name":"Cavanaugh Stefanie L.","position":1,"cik":"0001688530","reported_name":"Cavanaugh Stefanie L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:18:40.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":16804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024."}],"balance_after":54976,"source":{"system":"sec-edgar","filing":"0000950170-24-096254","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024096254/ownership.xml","form_type":"4"}}],"next_cursor":"2024-08-13T20:18:40.000000Z,1435254"}